Suppr超能文献

专性细胞内细菌中的肽聚糖。

Peptidoglycan in obligate intracellular bacteria.

机构信息

The Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, NE2 4AX, UK.

Department of Agronomy, Food, Natural Resources, Animals and Environment (DAFNAE), University of Padova. Agripolis - V.le dell'Università, 16 | 35020 Legnaro Padova, Italy.

出版信息

Mol Microbiol. 2018 Jan;107(2):142-163. doi: 10.1111/mmi.13880. Epub 2017 Dec 12.

Abstract

Peptidoglycan is the predominant stress-bearing structure in the cell envelope of most bacteria, and also a potent stimulator of the eukaryotic immune system. Obligate intracellular bacteria replicate exclusively within the interior of living cells, an osmotically protected niche. Under these conditions peptidoglycan is not necessarily needed to maintain the integrity of the bacterial cell. Moreover, the presence of peptidoglycan puts bacteria at risk of detection and destruction by host peptidoglycan recognition factors and downstream effectors. This has resulted in a selective pressure and opportunity to reduce the levels of peptidoglycan. In this review we have analysed the occurrence of genes involved in peptidoglycan metabolism across the major obligate intracellular bacterial species. From this comparative analysis, we have identified a group of predicted 'peptidoglycan-intermediate' organisms that includes the Chlamydiae, Orientia tsutsugamushi, Wolbachia and Anaplasma marginale. This grouping is likely to reflect biological differences in their infection cycle compared with peptidoglycan-negative obligate intracellular bacteria such as Ehrlichia and Anaplasma phagocytophilum, as well as obligate intracellular bacteria with classical peptidoglycan such as Coxiella, Buchnera and members of the Rickettsia genus. The signature gene set of the peptidoglycan-intermediate group reveals insights into minimal enzymatic requirements for building a peptidoglycan-like sacculus and/or division septum.

摘要

肽聚糖是大多数细菌细胞包膜中的主要抗压结构,也是真核免疫系统的有效刺激物。专性细胞内细菌仅在活细胞内部复制,这是一个渗透保护的小生境。在这些条件下,肽聚糖不一定需要维持细菌细胞的完整性。此外,肽聚糖的存在使细菌面临被宿主肽聚糖识别因子和下游效应物检测和破坏的风险。这导致了选择性压力和减少肽聚糖水平的机会。在这篇综述中,我们分析了主要专性细胞内细菌物种中涉及肽聚糖代谢的基因的发生情况。通过这种比较分析,我们确定了一组预测的“肽聚糖中间体”生物,其中包括衣原体、恙虫病东方体、沃尔巴克氏体和边缘无浆体。这种分组可能反映了它们与肽聚糖阴性专性细胞内细菌(如埃立克体和嗜吞噬细胞无形体)以及具有经典肽聚糖的专性细胞内细菌(如柯克斯氏体、布氏杆菌和立克次氏体属成员)在感染周期中的生物学差异。肽聚糖中间体组的特征基因集揭示了构建肽聚糖样囊泡和/或分裂隔膜的最小酶学要求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be15/5814848/5fee742538c8/MMI-107-142-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验